Skip to main content
U.S. flag

An official website of the United States government

Additional SAOs Which Are Not Included on Dun & Bradstreet List

The following companies meet the definition of 'substantially affected organizations' (SAO) even though they are not identified as such on the Dun & Bradstreet (D&B) listing (see List of SAOs and description of how SAOs are identified).

If an IC Ethics Official identifies a questionable entity and suggests inclusion on the SAO list, send sufficient information about the entity, including rationale for why it should be considered an SAO, to your assigned NEO Specialist for a determination. Confirmed entities will be added to this list. If an entity has additional information available, the name is linked to the other information.

Format: Entity Name (Date added to list - Month/Year)

23andMe (ME) (12/21) Mahana Therapeutics (3/22)   
AbbVie (3/13) Manhattan Scientifics Inc (MHTX) (03/17)
Acordia Therapeutics, Inc. (6/14) Medtronics (8/11)
Acceleron Pharma (11/18) Merus Labs International (Norgine BV) (MSLI) (12/18)
Affymetrix (11/06) MilliporeSigma (formerly known as EMD Millipore) (7/19)
Allakos, Inc (11/18) Mind Medicine, Inc. (MNMD) (4/22)
Anacore Pharmaceuticals, Inc. (6/14) Mindray Medical International Ltd (7/09)
Anavo Therapeutics (11/23) MST Medical Surgery Technologies, Inc. (8/13)
Applied DNA Sciences (APDN) (12/21) Nano-X Imaging Ltd. (NNOX) (4/21)
argenx SE (ARGX) (5/20) Neogenomics, Inc. (NEO) (3/20)
Aurinia Pharmaceutical Inc. (AUPH) (4/22) NovoCure Limited (NVCR) (6/21)
Avita Medical Limited (2/20) ObsEva SA (OBSV) (4/20)
Baxalta, Inc (Shire Plc) (12/18) Oncology Pharma, Inc. (ONPH) (3/22)
Bayer Aktiengesellschaft (8/19) Pacific Biosciences (4/13)
BioLineRx (BLRX) (4/21) PainReform Ltd. (11/22)
Bio-Rad Laboratories (8/06) PharmEnable (8//22)
Bio-Reference Laboratories (3/08) Photovac (4/06)
Bionano Genomics, Inc. (BNGO) (4/21) Portilla Pharmaceuticals (6/14)
BioNTech (BNTX) (11/21) Prana Biotechnology (3/12)
Braxia Scientific Corp. (BRAXF) (1/24) Procter & Gamble Company (P&G) (7/19)
Capstan Therapeutics (4/23) Propanc Biopharm, Inc. (PPCH) (11/18)
Cardinal Health (CAH) (5/16) ProQR Therapeutics N.V. (2/15)
Check Cap LTD (CHEK) Qiagen (8/08)
China Medical Technologies (2/10) QLT Inc, Vancouver, Canada (5/10)
Clovis Oncology (4/23) ReceptoPharm (12/18)
CRISPR Therapeutics (CRSP) (4/21) Relief Therapeutics Holding SA (RLFTF) (4/21)
DNAPrint Genomics, Inc. (5/11) Sagent Pharmaceuticals, Inc. (5/14)
Elysium Therapeutics, Inc. (6/13) Seagen, Inc. (SGEN) (6/21)
EssilorLuxottica (ESLOY) (8/21) Shenzhen Mindray Biomedical Electronics (7/09)
FlexBioTech (3/23) Smith & Nephew (8/10)
FSD Pharma Inc. (HUGE) (4/23) Surgivision (4/06)
Galena (GALE) Biopharma, Inc. (7/13) Symmetry Medical (4/07)
GeneDx (2/10) TaiMed Biologics (12/18)
General Electric Capital (GEH) (11/18) Taysha Gene Therapies (TSHA) (1/22)
General Electric HealthCare (GEHC) (2/23) Techniplast, USA (10/07)
Generex Biotechnology Crop (5/11) Tekla Healthcare Opportunities (7/14)
Given Imaging (5/06) Tekmira Pharmaceuticals (8/14)
GW Pharmaceuticals (09/13) The Institute for In Vitro Sciences, Inc (7/22)
Healthpure, Inc. (05/17) The McConnell Group (10/07)
Hospira (4/13) TomoTherapy (7/08)
Hypermarcas S.A. (3/15) Transgenomic (2/12)
IQVIA - formerly Quintiles IMS Holdings Inc (IVQ) (12/18) Trinity Biotech (10/14)
Illumina Inc. (6/14) Unimicro Technologies (7/08)
Immunotech Laboratories (IMBB) (12/18) Viataris Inc. (VTRS) (4/21)
InMode (INMD) (11/21) VolitionRX (VNRX) (4/21)
Isarna Therapeutics (5/14) West Pharmaceutical Services, Inc. (3/23)
Kinetic Concepts, Inc. (6/09) World Precision Instruments (10/07)                                       
Lab Products, Inc (10/07) Wuxi Pharma Tech (4/14)
Lannett Co. Inc (LCI) (12/18)  

                                                                                                                                                                      Updated: 02/23/2024


SAO Links:                                                                                                                                                             

For additional information, contact your IC's Deputy Ethics Counselor or Ethics Coordinator.